Clarification from Russian expert organization regarding telmisartan BE studies [Regulatives / Guidelines]

posted by Beholder  – Russia, 2019-11-08 07:51  – Posting: # 20764
Views: 2,084

(edited by Beholder on 2019-11-08 11:27)

Hi to all!

An article which might serve as "guideline" for conducting telmisartan BE studies in Russia written by expert organization representative. Open access and abstract in English is available.

Main points represented in the article:
  1. 7 BE studies performed in Russia were assessed.
  2. Not only males should be enrolled but females as well (50/50).
  3. HPLC FLD is, in some cases, more sensitive than HPLC MS/MS (see study 3) ;-).

Best regards
Beholder

Complete thread:

Activity
 Admin contact
20,258 posts in 4,264 threads, 1,397 registered users;
online 15 (1 registered, 14 guests [including 10 identified bots]).
Forum time (Europe/Vienna): 21:53 CET

You should treat as many patients as possible with the new drugs
while they still have the power to heal.    Armand Trousseau

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5